Eagle Asset Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Eagle Asset Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-290,369	Closed	-$1.62M	–	668
2015 Q4	$1.62M	Buy	290,369 +362	+0.1%	+$2.39K	0.01%	565
2015 Q3	$2.45M	Buy	290,007 +88,913	+44%	+$1.5M	0.02%	522
2015 Q2	$3.04M	Sell	201,094 -1,171	-0.6%	-$16.9K	0.02%	507
2015 Q1	$3.24M	Buy	+202,265	New	+$3.6M	0.02%	472
2014 Q4	–	Sell	-226,475	Closed	-$2.27M	–	656
2014 Q3	$2.27M	Sell	226,475 -16,186	-7%	-$196K	0.01%	563
2014 Q2	$3.79M	Sell	242,661 -106,387	-30%	-$1.51M	0.02%	502
2014 Q1	$6.48M	Buy	+349,048	New	+$6.99M	0.04%	424

Other funds holding PETX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Eagle Asset Management's PETX Position: Q1 2016 in Review

Eagle Asset Management sold out of Aratana Therapeutics, Inc. (PETX) in Q1 2016, closing a stake of 290,369 shares — an estimated $1.62M sold.

Eagle Asset Management first reported a position in PETX in Q1 2014 and held it in 7 quarters. The position peaked at $6.48M in Q1 2014. 95 funds tracked by Wall St. Rank hold PETX as of Q1 2016.

Eagle Asset Management reported no remaining Aratana Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
Eagle Asset Management sold 290,369 Aratana Therapeutics, Inc. shares in Q1 2016, an estimated $1.62M.
Eagle Asset Management first reported a position in Aratana Therapeutics, Inc. in Q1 2014 and held it in 7 quarters.
Eagle Asset Management's Aratana Therapeutics, Inc. position peaked at $6.48M in Q1 2014.
95 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2016.

Based on Eagle Asset Management's 13F filing for Q1 2016, filed 8 Apr 2016.